Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?

International Journal of Surgical Pathology

Volumn 10, Issue 4, 2002, Pages 267-272

  Paessler, Michele ^a   Kreisel, Friederike H C ^a   LiVolsi, Virginia A ^a   Akslen, Lars A ^b   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Metastasis; Papillary carcinoma; Thyroid; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; CHILD; LYMPH NODE; MIDDLE AGED; MULTIPLE CANCER; PAPILLARY CARCINOMA; PATHOLOGY; RETROSPECTIVE STUDY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0036817914     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690201000404     Document Type: Article

References (29)

1. LiVolsi VA, Fadda G, Baloch ZW. Prognostic factors in well-differentiated thyroid cancer. Curr Diagn Pathol 6:151-164, 2000
2. Gardner RE, Tuttle M, Burman KD, Hadddady S, Turman C, Sparling YH, Wartofsky L, Sessions RB, Ringel MD. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 126:309-312, 2000
3. Mazzaferri EL. Recombinant human thyrotropin symposium. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421-427, 1999
4. Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: Effect of therapy. Endocrine Pract 6:469-476, 2000
5. Treseler PA, Clark OH. Prognostic factors in thyroid carcinoma. Surg Oncol Clin North Am 6:555-598, 1997
6. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A populationbased study of 15,698 cases from the surveillance epidemiology and end results (SEER) program 1973-1991. Cancer 79(3):564-573, 1997
7. Orlo CH, Quan-Yang D. Textbook of Endocrine Surgery. Saunders, Philadelphia, pp. 90-93, 1997
8. Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well-differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81:333-339, 1996
9. Strogla A, Umal M, Kocaoglu JH. Total thyroidectomy for differentiated thyroid carcinoma: Primary and secondary operations. Eur J Surg Oncol 24(4):283-287, 1998
10. Mourand M, Malaise J, Michel JM, Mauel E, Squifflet JP. Surgical treatment of thyroid papillary carcinoma: Current controversies [Review]. Acta Otorhinolaryngol Belg 53(3):165-171, 1999
11. Goldman ND, Coniglio JU, Falk SA. Thyroid cancers. I. Papillary, follicular, and Hurthle cell. Otolaryngol Clin North Am 29:593-609, 1996
12. Soh EY, Clark OH. Surgical considerations and approaches to thyroid cancer. Endocrinol Metab Clin North Am 25:115-139, 1996
13. Kahky MP, Weber RS. Complications of surgery of the thyroid and parathyroid glands. Surg Clin North Am 73(2):307-321, 1993
14. Santini J, Haddad A. Total thyroidectomy is the recommended treatment for all papillary thyroid carcinoma [Review]. Acta Otorhinolaryngol Belg 53(3):161-164, 1999
15. Hay ID, Taylor WF, McConahey WM. A prognostic score for predicting outcome in papillary thyroid carcinoma. Endocrinology. 119(Suppl):1-15, 1986
16. Rossi RL, Cady B, Silverman W, Wool MS, Homer TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 10:612-622, 1986
17. Inabnet WB. Surgical management of thyroid cancer. Endocrine Pract 6(6):465-468, 2000
18. Hay ID. Papillary thyroid carcinoma. Endocrin Metab Clin North Am 19:545, 1990
19. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in a differentiated carcinoma of the thyroid. Am J Surg 164:658-661, 1992
20. Sanders LE, Cady B. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment. Arch Surg 133:419-425, 1998
21. Hay ID, Bergsrach EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057, 1993
22. Hay ID, Grant CS, Taylor WF, McConahey WM. Ispilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095, 1987
23. Fujimoto Y, Obara T, Ito Y, et al. Endocrine surgery in Japan and in our series. Endocrine Surg (Tokyo) 5:423, 1988
24. Fugimoto Y, Sugitani I. Postoperative prognosis of intrathyroidal papillary thyroid carcinoma: Long-term follow-up study. Endocrine J 45(4):475-484, 1988
25. Asanuma K, Kobayashi S, Sugenoya A, Yokoyama S, Shingu K, Hama Y, Itoh N, Kasuga Y, Amano J. Clinical recurrence of papillary thyroid cancer in the remnant lobe. Eur J Surg 166(3):202-206, 2000
26. Williams ED, Abrosimov A, Bogdanova TI, et al. Two proposals regarding the terminology of thyroid tumors [editorial]. Int J Surg Pathol 8:181-183, 2000
27. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid. Bane of the pathologist. Am J Clin Pathol 111:216-222, 2000
28. Hay ID, Gram CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124(6):958-964; discussion 964-966, 1998
29. Inabnet WB, Fisher S, Staren ED. Thyroid and parathyroid ultrasound. Probl Gen Surg 14:54-65, 1997